Loading...

Klotho Neurosciences, Inc.

KLTOW•NASDAQ
Healthcare
Biotechnology
$0.25
$-0.00(-0.00%)

Klotho Neurosciences, Inc. (KLTOW) Stock Overview

Explore Klotho Neurosciences, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 61.9/100

Key Financials

Market Cap8.4M
P/E Ratio0.00
EPS (TTM)N/A
ROE-13.45%
Fundamental Analysis

AI Price Forecasts

1 Week$0.03
1 Month$0.01
3 Months$0.00
1 Year Target$0.02

KLTOW Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Klotho Neurosciences, Inc. (KLTOW) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $0.02.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 0.00 and a market capitalization of 8.4M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Stats data is not available for KLTOWStats details for KLTOW are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Analyst Recommendations data is not available for KLTOWAnalyst Recommendations details for KLTOW are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Company Profile

Klotho Neurosciences, Inc., a biopharmaceutical company, develops medicines for the treatment of cancer, cardiovascular, and neurodegenerative disorders. Its lead gene therapy product candidates include AMI-101 for the treatment or prevention of Alzheimer's disease; and AMI-202 to treat and prevent amyotrophic lateral sclerosis. The company was formerly known as Anew Medical, Inc. and changed its name to Klotho Neurosciences, Inc. in September 2024. The company is based in Omaha, Nebraska.

CEO

Joseph Sinkule

Employees

3

Headquarters

13576 Walnut Street, Omaha, NE

Founded

1970

Frequently Asked Questions

;